“…Finding selective drugs with low toxicity to normal cells that are not Pgp substrates may thus be one of the ways to effectively treat this disease. Several studies concerning the evaluation of the biologic activity of xanthones demonstrated that they often present anti-tumor activity [13,[30][31][32], besides many other interesting biological activities, including anti-oxidant, anti-inflammatory, anti-allergy, anti-bacterial, anti-fungal, and anti-viral activities [12,33,34]. Some cell targets for xanthone derivatives have already been described and include, among others, cyclin dependent kinases, important in cell cycle control [35,36], cytokines, kinases that modulate the activity of PI3K, Akt, and TOR proteins or proteins involved in apoptosis, like Bax, Bcl-2, or caspase 3 [37].…”